Links Between Infectious Diseases and Cardiovascular Disease: A Growing Body of Evidence
Abstract
It is widely acknowledged that a systemic inflammatory process is involved in atherogenesis leading to subsequent cardiovascular disease (CVD). Several types of microbes have been implicated as possible causative agents in acquired CVD. This article reviews current and emerging links established between specific microorganisms and cardiac vessel and other vascular damage. Studies are reviewed that have investigated a possible role for antibiotics in treatment and prevention; other potential primary and secondary preventive measures are then explored. Nurse practitioners have an important role in recognizing and effectively managing the multiple complex processes involved in the development of CVD.
The authors, reviewers, and editors all report no financial relationships that pose a conflict of interest. The authors do not present any off-label or non-FDA-approved recommendations for treatment. There is no implied endorsement by NPA, MNA, or ANCC of any commercial products mentioned in this article.
In compliance with national ethical guidelines, the authors report no relationships with business or industry that would pose a conflict of interest.
1Kim Curry, PhD, ARNP, is an assistant professor in the department of nursing at the University of Tampa in Florida.
2Lauren Lawson, PhD, RN, is an associate professor in the department.